Kyu-Don Kim
Corporate Officer/Principal chez GENEXINE, INC.
Profil
Kyu-Don Kim is currently the Director of Operations at PT Kalbe Genexine Biologics and the President of the Executive Board at Genexine, Inc. Previously, he worked as the Vice President, Director, and Head of Management at Chong Kun Dang Pharmaceutical Corp.
in 2014.
He holds a doctorate degree from Northern Illinois University.
Postes actifs de Kyu-Don Kim
| Sociétés | Poste | Début |
|---|---|---|
| GENEXINE, INC. | Corporate Officer/Principal | - |
PT Kalbe Genexine Biologics
 PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Directeur des opérations | - |
Anciens postes connus de Kyu-Don Kim
| Sociétés | Poste | Fin |
|---|---|---|
| CHONG KUN DANG PHARMACEUTICAL CORP. | Directeur Général | - |
Formation de Kyu-Don Kim
| Northern Illinois University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CHONG KUN DANG PHARMACEUTICAL CORP. | Health Technology |
| GENEXINE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
PT Kalbe Genexine Biologics
PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Health Technology |